In Vitro Activities of Tigecycline (GAR-936) against Multidrug-Resistant Staphylococcus aureus and Streptococcus pneumoniae [4]

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 1, 2004, Pages 366-367

  Kitzis, M D ^a   Ly, A ^a   Goldstein, F W ^a  

^a SAINT JOSEPH HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DALFOPRISTIN PLUS QUINUPRISTIN; LINEZOLID; MINOCYCLINE; TELITHROMYCIN; TETRACYCLINE; TIGECYCLINE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; COLONY FORMING UNIT; DRUG ACTIVITY; IN VITRO STUDY; LETTER; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

DRUG RESISTANCE, MULTIPLE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; TETRACYCLINES;

EID: 0346731286     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.1.366-367.2004     Document Type: Letter

References (8)

1. Betriu, C., I. Rodriguez-Avial, B. A. Sanchez, M. Gomez, J. Alvarez, and J. J. Picazo. 2002. In vitro activities of tigecycline (GAR-936) against recently isolated clinical bacteria in Spain. Antimicrob. Agents Chemother. 46:892-895.
2. Boucher, H. W., C. B. Wennersten, and G. M. Eliopoulos. 2000. In vitro activities of the glycylcycline GAR-936 against gram-positive bacteria. Antimicrob. Agents Chemother. 44:2225-2229.
3. Chopra, I. 2001. Glycylcyclines: third-generation tetracycline antibiotics. Curr. Opin. Pharmacol. 1:464-469.
4. Goldstein, F. W. 1999. Penicillin-resistant Streptococcuspneumoniae: selection by beta-lactam and non-beta-lactam antibiotics. J. Antimicrob. Chemother. 44:141-144.
5. Leclercq, R. 2002. Staphylococci resistant to antibiotic therapy. Ann. Fr. Anesth. Reanim. 21:375-383.
6. Mainardi, J. L., D. M. Shlaes, R. V. Goering, J. H. Shlaes, J. F. Acar, and F. W. Goldstein. 1995. Decreased teicoplanin susceptibility of methicillin-resistant strains of Staphylococcus aureus. J. Infect. Dis. 171:1646-1650.
7. Petersen, P. J., N. V. Jacobus, W.J. Weiss, P. E. Sum, and R. T. Testa. 1999. In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936). Antimicrob. Agents Chemother. 43:738-744.
8. Schito, G. C., E. A. Debbia, and A. Marchese. 2000. The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project. J. Antimicrob. Chemother. 46(Suppl. T1):3-9.